Omega Healthcare Investors Financial Statements (OHI)
|
|
|
|
Report date
|
|
|
31.12.2022 |
14.02.2023 |
12.02.2024 |
13.02.2025 |
09.02.2026 |
|
29.04.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
878.2 |
878.2 |
949.7 |
1 051 |
1 198 |
|
1 239 |
|
Operating Income, bln rub |
|
|
78.6 |
392.3 |
489.0 |
659.7 |
749.4 |
|
797.2 |
|
EBITDA, bln rub |
? |
|
995.6 |
1 002 |
810.8 |
947.1 |
1 170 |
|
1 215 |
|
Net profit, bln rub |
? |
|
426.9 |
426.9 |
242.2 |
406.3 |
590.1 |
|
632.1 |
|
|
OCF, bln rub |
? |
|
0.000 |
625.7 |
626.5 |
749.4 |
878.6 |
|
915.8 |
|
CAPEX, bln rub |
? |
|
0.000 |
47.2 |
38.0 |
37.8 |
0.000 |
|
34.3 |
|
FCF, bln rub |
? |
|
0.000 |
578.5 |
588.5 |
712.7 |
878.6 |
|
907.1 |
|
Dividend payout, bln rub
|
|
|
0.000 |
632.9 |
643.9 |
685.4 |
780.4 |
|
789.6 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
148.2% |
265.9% |
168.7% |
132.2% |
|
124.9% |
|
|
OPEX, bln rub |
|
|
757.7 |
470.5 |
445.7 |
377.2 |
216.3 |
|
360.8 |
|
Cost of production, bln rub |
|
|
42.0 |
15.5 |
15.0 |
14.6 |
664.9 |
|
185.6 |
|
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
220.3 |
233.2 |
235.5 |
221.7 |
220.5 |
|
212.6 |
|
|
Assets, bln rub |
|
|
8 860 |
9 405 |
9 117 |
9 898 |
10 049 |
|
10 235 |
|
Net Assets, bln rub |
? |
|
3 609 |
3 609 |
3 575 |
4 537 |
5 181 |
|
5 191 |
|
Debt, bln rub |
|
|
19.2 |
5 287 |
5 067 |
4 839 |
4 256 |
|
4 441 |
|
Cash, bln rub |
|
|
305.6 |
297.1 |
442.8 |
518.3 |
27.0 |
|
26.1 |
|
Net debt, bln rub |
|
|
-286.4 |
4 990 |
4 625 |
4 321 |
4 229 |
|
4 415 |
|
|
Ordinary share price, rub |
|
|
28.0 |
28.0 |
30.7 |
37.9 |
44.3 |
|
47.9 |
|
Number of ordinary shares, mln |
|
|
227.7 |
236.3 |
240.5 |
258.1 |
296.1 |
|
297.0 |
|
|
Market cap, bln rub |
|
|
6 365 |
6 603 |
7 374 |
9 770 |
13 129 |
|
14 237 |
|
EV, bln rub |
? |
|
6 079 |
11 593 |
11 998 |
14 090 |
17 358 |
|
18 653 |
|
Book value, bln rub |
|
|
2 966 |
2 966 |
2 931 |
3 893 |
4 537 |
|
4 547 |
|
|
EPS, rub |
? |
|
1.87 |
1.81 |
1.01 |
1.57 |
1.99 |
|
2.13 |
|
FCF/share, rub |
|
|
0.00 |
2.45 |
2.45 |
2.76 |
2.97 |
|
3.05 |
|
BV/share, rub |
|
|
13.0 |
12.6 |
12.2 |
15.1 |
15.3 |
|
15.3 |
|
|
EBITDA margin, % |
? |
|
113.4% |
114.1% |
85.4% |
90.1% |
97.7% |
|
98.0% |
|
Net margin, % |
? |
|
48.6% |
48.6% |
25.5% |
38.6% |
49.3% |
|
51.0% |
|
FCF yield, % |
? |
|
0.00% |
8.76% |
7.98% |
7.29% |
6.69% |
|
6.37% |
|
ROE, % |
? |
|
11.8% |
11.8% |
6.78% |
8.96% |
11.4% |
|
12.2% |
|
ROA, % |
? |
|
4.82% |
4.54% |
2.66% |
4.11% |
5.87% |
|
6.18% |
|
|
P/E |
? |
|
14.9 |
15.5 |
30.4 |
24.0 |
22.2 |
|
22.5 |
|
P/FCF |
|
|
|
11.4 |
12.5 |
13.7 |
14.9 |
|
15.7 |
|
P/S |
? |
|
7.25 |
7.52 |
7.76 |
9.29 |
11.0 |
|
11.5 |
|
P/BV |
? |
|
2.15 |
2.23 |
2.52 |
2.51 |
2.89 |
|
3.13 |
|
EV/EBITDA |
? |
|
6.11 |
11.6 |
14.8 |
14.9 |
14.8 |
|
15.4 |
|
Debt/EBITDA |
|
|
-0.29 |
4.98 |
5.70 |
4.56 |
3.61 |
|
3.63 |
|
|
R&D/CAPEX, % |
|
|
|
0.00% |
0.00% |
0.00% |
|
|
0 |
|
|
CAPEX/Revenue, % |
|
|
0.00% |
5.38% |
4.00% |
3.59% |
0.00% |
|
2.77% |
|
| Omega Healthcare Investors shareholders |
